bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Blueprint Medicines Corporation logo

    Blueprint Medicines Corporation

    BPMC | NASDAQ
    Chart Builder DCF Calculator
    $129.46
    +$0.18 (+0.14%)
    At close: Jul 18, 2025, 04:00 PM ET
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $8.36B
    Enterprise Value
    $7.91B
    Beta
    0.83
    Average Volume
    N/A
    Shares Outstanding (Diluted)
    63.6M
    Shares Change YoY
    -0.32%
    Institutional Ownership
    96.61%
    Exchange
    N/A
    ISIN
    N/A

    Price Performance

    Price Change 1M
    N/A
    Price Change 3M
    N/A
    Price Change 6M
    N/A
    Price Change YTD
    N/A
    Price Change 1Y
    N/A
    Price Change 3Y
    N/A
    Price Change 5Y
    N/A
    1M CAGR (ann.)
    1.1%
    1Y CAGR (ann.)
    7.4%
    5Y CAGR (ann.)
    11.1%
    All-Time CAGR
    20.7%

    Valuation

    PE Ratio
    -52.41
    Forward PE
    35.10
    PEG Ratio
    0.58
    Forward PEG
    -0.41
    PS Ratio
    14.87
    Forward PS
    7.10
    PB Ratio
    24.44
    P/FCF Ratio
    -55.40
    P/Adj. FCF Ratio
    -31.59
    P/OCF Ratio
    -42.31
    EV/Sales
    14.07
    EV/EBIT
    -73.02
    EV/EBITDA
    -60.34
    EV/FCF
    -52.40
    Earnings Yield
    -1.9%
    FCF Yield
    -1.8%
    Adj. FCF Yield
    -3.2%

    Financial Health

    Net Cash
    $453.49M
    Total Debt
    $122.75M
    Cash & Short-Term Investments
    $576.24M
    Total Assets
    $1.2B
    Current Ratio
    2.85
    Quick Ratio
    2.80
    Debt / Equity Ratio
    1.57
    Debt / EBITDA
    -0.94
    Debt / FCF
    -0.81
    OCF / Debt
    -1.19
    Interest Coverage
    -3.08
    Altman Z-Score
    3.71
    Piotroski F-Score
    4

    Margins & Profitability

    Gross Profit Margin
    96.0%
    Operating Profit Margin
    -31.0%
    EBITDA Margin
    3.8%
    Net Profit Margin
    -13.2%
    FCF Margin
    -26.9%
    Adj. FCF Margin
    -47.1%
    SBC / Revenue
    21.4%
    SBC Impact (per share)
    -75.4%

    Returns

    Return on Assets
    -5.7%
    Return on Equity
    -31.3%
    Return on Invested Capital
    -21.7%
    Return on Capital Employed
    -23.1%
    Return on Tangible Assets
    -5.7%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    36.5%
    Revenue CAGR 5Y
    50.9%
    Revenue CAGR 10Y
    96.6%
    EPS CAGR 3Y
    63.9%
    EPS CAGR 5Y
    -22.2%
    EPS CAGR 10Y
    -5.7%
    FCF CAGR 3Y
    48.7%
    FCF CAGR 5Y
    -35.1%
    FCF CAGR 10Y
    -16.7%

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    34
    EPS Growth Next 3Y
    144.3%
    Revenue Growth Next 3Y
    42.7%
    Earnings Date
    Apr 30, 2025
    EPS Estimate (next Q)
    -$0.42
    EPS Growth Est (next Q)
    -68.2%
    Revenue Est (next Q)
    $172.8M
    Revenue Growth Est (next Q)
    79.8%

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $113.07
    Price Target Upside
    -12.7%

    Cash Flow

    Operating Cash Flow
    $-145.55M
    Free Cash Flow
    $-150.91M
    Adj. Free Cash Flow
    $-264.65M
    FCF Per Share
    -$3.14
    OCF Per Share
    -$3.06
    OCF/S Ratio
    -37.8%

    Income Statement

    Revenue
    $562.12M
    Gross Profit
    $538.73M
    Operating Income
    $-174.31M
    EBITDA
    $-131.05M
    Net Income
    $-155.73M
    EPS (Diluted)
    -$2.47
    Revenue / Employee
    N/A
    Profit / Employee
    N/A
    Employees
    N/A

    © 2026 bestshares.com. All rights reserved.